| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $10.81B | $10.39B | $10.47B |
| YoY Revenue Growth % | +4.1% | -0.8% | — |
| Gross Profit | $2.07B | $1.93B | — |
| Gross Margin % | 19.2% | 18.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.09B | $979.0M | $690.0M |
| Operating Margin % | 10.1% | 9.4% | 6.6% |
| Net Income (GAAP) | $735.0M | $646.0M | $488.0M |
| EBITDA (Normalized) | $1.44B | $1.44B | $1.07B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.16B | $1.06B | $982.0M |
| Capital Expenditures (CapEx) | $441.0M | $579.0M | $471.4M |
| Free Cash Flow (FCF) | $716.0M | $480.0M | $510.6M |
| FCF Margin % | 6.6% | 4.6% | 4.9% |
| Return on Invested Capital (ROIC %) | 23.2% | 22.3% | 7.2% |
| Cash & Short-Term Equivalents | $604.0M | $330.0M | — |
| Total Debt (Short + Long Term) | $1.73B | $1.52B | $2.94B |
| Total Stockholders' Equity | $2.57B | $2.28B | $6.03B |